Jared Weiss, MD
Advertisement
Articles by Jared Weiss, MD
Advertisement
Latest Updated Articles
Clinical Impact of Chemo-Induced Myelosuppression in ES-SCLCPublished: August 26th 2021 | Updated:
Progress in the Treatment and Management of SCLCPublished: July 6th 2022 | Updated:
Chemo-Induced Myelosuppression in ES-SCLCPublished: August 26th 2021 | Updated:
Management of Adverse Events Associated with Durvalumab + ChemotherapyPublished: July 11th 2022 | Updated:
Patient Profile 1: A 68-Year-Old Male with SCLC and Brain MetastasesPublished: July 6th 2022 | Updated:
- Second Line Treatment Options in SCLC and Selecting the Appropriate Therapy
Published: July 29th 2022 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
4
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
5